Chronic pain impacts about 20% of US Adults. Though non-pharmacologic, integrative pain management therapies are now considered first-line treatment by clinical guidelines, these therapies are still rarely covered by health insurance and therefore inaccessible to lower-income individuals. The Integrative Medical Group Visit (IMGV) program was developed to offer low-income, diverse patients with chronic pain an introduction to integrative pain management approaches, through a model that is covered by health insurance under existing billing codes. An initial pragmatic randomized control trial found that IMGV led to significant improvement in mental health related quality of life and lower use of high-cost care. However, there has been little research investigating the implementation of IMGV, and none in Federally-Qualified Health Centers (FQHCs), where the program was initially designed to be implemented. In this study, the investigators test strategies to implement IMGV in FQHCs, including training and coaching clinic staff, and measure the effectiveness of the IMGV on health outcomes for patients with chronic pain.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Reach: Total Patients Reached
Timeframe: through study completion, a total of up to 3 years
Reach: Race of Patients Reached
Timeframe: through study completion, a total of up to 3 years
Reach: Ethnicity of Patients Reached
Timeframe: through study completion, a total of up to 3 years
Reach: Gender of Patients Reached
Timeframe: through study completion, a total of up to 3 years
Reach: Age of Patients Reached
Timeframe: through study completion, a total of up to 3 years
Adoption
Timeframe: through study completion, a total of up to 3 years
Acceptability: Patients
Timeframe: within 1 month of final IMGV session participation, approximately 10 weeks
Acceptability: Clinic Personnel
Timeframe: within 1 month of final IMGV session participation, approximately 10 weeks
Cost: Patient Perspective
Timeframe: within 1 month of final IMGV session participation, approximately 10 weeks
Cost: Clinic Perspective
Timeframe: within 1 month of final IMGV session participation, approximately 10 weeks
Fidelity
Timeframe: Through completion of IMGV delivery, a total of up to two years
Maintenance: 6 months
Timeframe: Six months after the first IMGV session at clinic
Maintenance: 12 months
Timeframe: Twelve months after the first IMGV session at clinic